Aliases & Classifications for Dysphagia

MalaCards integrated aliases for Dysphagia:

Name: Dysphagia 54 29 55 6
Deglutition Disorders 73

Classifications:



External Ids:

ICD10 33 R13
UMLS 73 C0011168

Summaries for Dysphagia

NINDS : 54 Having trouble swallowing (dysphagia) is a symptom that accompanies a number of neurological disorders. The problem can occur at any stage of the normal swallowing process as food and liquid move from the mouth, down the back of the throat, through the esophagus and into the stomach. Difficulties can range from a total inability to swallow, to coughing or choking because the food or liquid is entering the windpipe, which is referred to as aspiration. When aspiration is frequent a person can be at risk of developing pneumonia. Food may get "stuck" in the throat or individuals may drool because they cannot swallow their saliva. Neurological conditions that can cause swallowing difficulties are: stroke (the most common cause of dysphagia); traumatic brain injury; cerebral palsy; Parkinson disease and other degenerative neurological disorders such as amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease), multiple sclerosis, progressive supranuclear palsy, Huntington disease, and myasthenia gravis. Muscular dystrophy and myotonic dystrophy are accompanied by dysphagia, which is also the cardinal symptom of oculopharyngeal muscular dystrophy, a rare, progressive genetic disorder.

MalaCards based summary : Dysphagia, also known as deglutition disorders, is related to leigh syndrome and myopathy, areflexia, respiratory distress, and dysphagia, early-onset, and has symptoms including seizures, nausea and vomiting and constipation. An important gene associated with Dysphagia is MEGF10 (Multiple EGF Like Domains 10), and among its related pathways/superpathways is GABAergic synapse. The drugs Methylene blue and Fluorouracil have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and tongue, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Increased shRNA abundance (Z-score > 2)

Wikipedia : 76 Dysphagia is the medical term for the symptom of difficulty in swallowing. Although classified under... more...

Related Diseases for Dysphagia

Diseases related to Dysphagia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 477)
# Related Disease Score Top Affiliating Genes
1 leigh syndrome 30.4 NDUFA10 NDUFA12 NDUFA9 SCO2
2 myopathy, areflexia, respiratory distress, and dysphagia, early-onset 12.6
3 odontoma-dysphagia syndrome 12.4
4 dysphagia lusoria 12.4
5 plummer vinson syndrome 12.1
6 opitz-gbbb syndrome 11.7
7 oculopharyngeal muscular dystrophy 11.5
8 swallowing disorders 11.5
9 chronic progressive external ophthalmoplegia 11.3
10 jackhammer esophagus 11.3
11 aspiration pneumonia 11.2
12 esophagitis, eosinophilic, 1 11.2
13 opitz gbbb syndrome, type ii 11.2
14 esophageal tuberculosis 11.2
15 aberrant subclavian artery 11.2
16 myasthenia gravis 11.2
17 pseudobulbar palsy 11.1
18 achalasia, familial esophageal 11.1
19 spinal and bulbar muscular atrophy, x-linked 1 11.1
20 central pontine myelinolysis 11.1
21 striatonigral degeneration, infantile 11.0
22 neurodegeneration with brain iron accumulation 3 11.0
23 thiamine metabolism dysfunction syndrome 2 11.0
24 chromosome 1p36 deletion syndrome 11.0
25 leukodystrophy, hypomyelinating, 15 11.0
26 distal myopathy with vocal cord weakness 11.0
27 dystonia 12 10.8
28 oculopharyngodistal myopathy 10.8
29 spinocerebellar ataxia 7 10.8
30 scapuloperoneal syndrome, neurogenic, kaeser type 10.8
31 thyroglossal duct cyst, familial 10.8
32 achalasia-microcephaly syndrome 10.8
33 fazio-londe disease 10.8
34 niemann-pick disease, type c1 10.8
35 wilson disease 10.8
36 mohr-tranebjaerg syndrome 10.8
37 leber optic atrophy and dystonia 10.8
38 cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss 10.8
39 spinocerebellar ataxia 13 10.8
40 paraganglioma and gastric stromal sarcoma 10.8
41 spinocerebellar ataxia 17 10.8
42 spastic paralysis, infantile-onset ascending 10.8
43 spinocerebellar ataxia 27 10.8
44 pontocerebellar hypoplasia, type 6 10.8
45 neurodegeneration with brain iron accumulation 4 10.8
46 peroxisome biogenesis disorder 8b 10.8
47 pontocerebellar hypoplasia, type 2e 10.8
48 myoclonus, intractable, neonatal 10.8
49 autosomal dominant limb-girdle muscular dystrophy type 1a 10.8
50 laryngeal tuberculosis 10.8

Graphical network of the top 20 diseases related to Dysphagia:



Diseases related to Dysphagia

Symptoms & Phenotypes for Dysphagia

UMLS symptoms related to Dysphagia:


seizures, nausea and vomiting, constipation, vomiting, abdominal pain, diarrhea, headache, pseudobulbar signs, nausea, icterus, signs and symptoms, digestive, dyspepsia, heartburn, gastrointestinal gas, digestive system symptom, flatulence, eructation, and gas pain, symptoms involving digestive system, other symptoms involving digestive system, odynophagia, pain in esophagus (finding), absent deglutition, swallowing problems, choking sensation, symptom as reason for upper g.i. examination, dysphagia, pharyngeal phase, dysphagia, pharyngoesophageal phase

GenomeRNAi Phenotypes related to Dysphagia according to GeneCards Suite gene sharing:

26 (show all 22)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-100 10.08 PABPN1
2 Increased shRNA abundance (Z-score > 2) GR00366-A-107 10.08 NDUFA10
3 Increased shRNA abundance (Z-score > 2) GR00366-A-108 10.08 SCO2
4 Increased shRNA abundance (Z-score > 2) GR00366-A-115 10.08 NDUFA9 NDUFA10 PABPN1
5 Increased shRNA abundance (Z-score > 2) GR00366-A-120 10.08 NDUFA10
6 Increased shRNA abundance (Z-score > 2) GR00366-A-126 10.08 SCO2
7 Increased shRNA abundance (Z-score > 2) GR00366-A-129 10.08 NDUFA9 SCO2
8 Increased shRNA abundance (Z-score > 2) GR00366-A-146 10.08 SCO2
9 Increased shRNA abundance (Z-score > 2) GR00366-A-166 10.08 NDUFA9 NDUFA10 PABPN1
10 Increased shRNA abundance (Z-score > 2) GR00366-A-168 10.08 NDUFA10
11 Increased shRNA abundance (Z-score > 2) GR00366-A-169 10.08 PABPN1
12 Increased shRNA abundance (Z-score > 2) GR00366-A-176 10.08 NDUFA10
13 Increased shRNA abundance (Z-score > 2) GR00366-A-182 10.08 PABPN1
14 Increased shRNA abundance (Z-score > 2) GR00366-A-183 10.08 NDUFA10
15 Increased shRNA abundance (Z-score > 2) GR00366-A-214 10.08 PABPN1
16 Increased shRNA abundance (Z-score > 2) GR00366-A-24 10.08 SCO2
17 Increased shRNA abundance (Z-score > 2) GR00366-A-43 10.08 PABPN1
18 Increased shRNA abundance (Z-score > 2) GR00366-A-57 10.08 NDUFA9 NDUFA10
19 Increased shRNA abundance (Z-score > 2) GR00366-A-63 10.08 NDUFA10
20 Increased shRNA abundance (Z-score > 2) GR00366-A-73 10.08 NDUFA9
21 Increased shRNA abundance (Z-score > 2) GR00366-A-76 10.08 NDUFA10
22 Increased shRNA abundance (Z-score > 2) GR00366-A-81 10.08 NDUFA9

Drugs & Therapeutics for Dysphagia

Drugs for Dysphagia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 619)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Methylene blue Approved, Investigational Phase 4,Phase 1,Phase 2,Not Applicable 61-73-4
2
Fluorouracil Approved Phase 4,Phase 3,Phase 2,Not Applicable 51-21-8 3385
3
Cetuximab Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 205923-56-4 56842117 2333
4
Alginic acid Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 9005-32-7
5
Domperidone Approved, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable 57808-66-9 3151
6
Dopamine Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 51-61-6, 62-31-7 681
7
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 73590-58-6 4594
8
Calcium polycarbophil Approved Phase 4 126040-58-2
9
Rabeprazole Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 117976-89-3 5029
10
Trimebutine Approved Phase 4 39133-31-8
11
Lansoprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 103577-45-3 3883
12
Dexlansoprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 103577-45-3, 138530-94-6 9578005
13
Esomeprazole Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 161796-78-7, 119141-88-7 4594 9579578
14
mometasone furoate Approved, Vet_approved Phase 4,Phase 2 83919-23-7
15
Acetylcholine Approved Phase 4,Phase 3,Phase 2,Not Applicable 51-84-3 187
16
Acetaminophen Approved Phase 4,Phase 3,Not Applicable 103-90-2 1983
17
Chlorhexidine Approved, Vet_approved Phase 4,Phase 3,Not Applicable 55-56-1 2713 9552079
18
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable 437-38-7 3345
19
Epinephrine Approved, Vet_approved Phase 4,Not Applicable 51-43-4 5816
20
Racepinephrine Approved Phase 4,Not Applicable 329-65-7 838
21
Pantoprazole Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 102625-70-7 4679
22
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 1177-87-3
23
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 50-02-2 5743
24
Fluticasone Approved, Experimental Phase 4,Phase 3,Phase 2,Not Applicable 90566-53-3 62924
25
Zinc Approved, Investigational Phase 4,Not Applicable 7440-66-6
26
Remifentanil Approved Phase 4 132875-61-7 60815
27
Levobupivacaine Approved, Investigational Phase 4 27262-47-1 92253
28
Bupivacaine Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 2180-92-9, 38396-39-3 2474
29
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 94-09-7, 1994-09-7 2337
30 tannic acid Approved Phase 4,Phase 3,Phase 2,Not Applicable
31
Tyrothricin Approved Phase 4 1404-88-2
32
Famotidine Approved Phase 4,Phase 2,Phase 3,Not Applicable 76824-35-6 3325
33
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 51-45-6, 75614-87-8 774
34
Naloxone Approved, Vet_approved Phase 4 465-65-6 5284596
35
Metoclopramide Approved, Investigational Phase 4,Phase 3,Not Applicable 364-62-5 4168
36
Benzydamine Approved Phase 4,Phase 1 100-46-9, 642-72-8 7504
37
Morphine Approved, Investigational Phase 4,Not Applicable 57-27-2 5288826
38
Isoflurane Approved, Vet_approved Phase 4 26675-46-7 3763
39
Rocuronium Approved Phase 4,Early Phase 1 119302-91-9, 143558-00-3 441290
40
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable 2078-54-8 4943
41
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
42
Tacrolimus Approved, Investigational Phase 4 104987-11-3 445643 439492
43
Nystatin Approved, Vet_approved Phase 4 1400-61-9 11953884
44
Clotrimazole Approved, Vet_approved Phase 4,Phase 3 23593-75-1 2812
45
Propranolol Approved, Investigational Phase 4 525-66-6 4946
46
Oxybutynin Approved, Investigational Phase 4,Phase 3 5633-20-5 4634
47
Meloxicam Approved, Vet_approved Phase 4 71125-38-7 54677470 5281106
48
Diclofenac Approved, Vet_approved Phase 4,Phase 2,Phase 3 15307-86-5 3033
49
Magnesium hydroxide Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 1309-42-8
50 Magnesium trisilicate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 14987-04-3

Interventional clinical trials:

(show top 50) (show all 1661)
# Name Status NCT ID Phase Drugs
1 Personalized Peroral Endoscopic Myotomy for Achalasia Unknown status NCT01570621 Phase 4
2 Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck Unknown status NCT02015650 Phase 4 Cetuximab;Mitomycin-C/ 5-Fluorouracil
3 Evaluation of Low-level Laser at Auriculotherapy Points to Reduce Postoperative Pain in Inferior Third Molar Surgery Unknown status NCT02657174 Phase 4
4 Effect of Magnesium Alginate on Gastroesophageal Reflux in Infants. Unknown status NCT02806453 Phase 4
5 Research of Efficient Use of Omeprazole in Combination With Domperidone in Gastroesophageal Reflux Disease of Mild to Moderate Severity Unknown status NCT02140073 Phase 4 omeprazole+domperidone SR;omeprazole
6 Phase IV Study of the Impact of Dietary Fibers on Symptoms and Esophageal Motility in Patients With Non-erosive GERD Unknown status NCT01882088 Phase 4 Mucofalk
7 Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Wu-Chu-Yu Tang on Gastroesophageal Reflux Disease (GERD) Unknown status NCT01822106 Phase 4
8 Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance Unknown status NCT01503476 Phase 4
9 LGG for Prevention of Infectious Complications During PPI Treatment in Children Unknown status NCT01782118 Phase 4
10 Trimebutine Maleate Combined With Rabeprazole in Patients With Grade A or B Reflux Esophagitis Whose Symptoms Refractory to Rabeprazole Unknown status NCT02986685 Phase 4 Trimebutine Maleate;rabeprazole
11 Treatment Effect Between Dexlansoprazole and Double-dose Lansoprazole in Obesity Patients With Reflux Esophagitis Unknown status NCT02759393 Phase 4 Dexlansoprazole;Lansoprazole
12 Esomeprazole Plus Alginate vs. Esomeprazole Alone for Treatment of Nighttime Reflux Symptom and Sleep Disturbances Unknown status NCT02277886 Phase 4 sodium alginate;esomeprazole
13 Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy Unknown status NCT01328652 Phase 4 dexlansoprazole
14 Transoral Incisionless Fundoplication (TIF) Versus Sham for Treatment of Gastroesophageal Reflux Disease (GERD) Unknown status NCT01110811 Phase 4
15 The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate Unknown status NCT02278081 Phase 4 lansoprazole;placebo
16 A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy. Unknown status NCT00237068 Phase 4 Lansoprazole; Solutab
17 Evaluation of Two Different Thickening Products in Patients With Dysphagia Completed NCT01651975 Phase 4
18 Pediatric Dysphagia Outcomes After Injection Laryngoplasty for Type I Laryngeal Cleft Completed NCT01507207 Phase 4
19 Neuromuscular Electroestimulation and Respiratory Muscle Training in Subacute Stroke Completed NCT02473432 Phase 4
20 Repetitive Transcranial Stimulation (rTMS) in Post Stroke Dysphagia Completed NCT01081444 Phase 4
21 Opioid Induced Swallowing Difficulties and Risk for Pulmonary Aspiration Completed NCT01495377 Phase 4 Remifentanil;Placebo;Technetium
22 Effect of Laryngeal Mask Cuff Pressure in Geriatric Patients Completed NCT02189954 Phase 4
23 Peritonsillar Infiltration With Levobupivacaine for Posttonsillectomy Pain Completed NCT02322346 Phase 4 Group LL;Group HL
24 Comparison of Efficacy and Safety of Two Different Types of Botulinum Toxin Type A in Moderate to Severe Cervical Dystonia Completed NCT00528541 Phase 4
25 Safety and Efficacy of a Sore Throat Lozenge DORITHRICIN in Patients With Acute Pharyngitis Completed NCT03323528 Phase 4 Benzalkonium Chloride-Benzocaine Topical;Placebo Oral Tablet
26 Acetaminophen's Efficacy For Post-operative Pain Completed NCT01721486 Phase 4 IV acetaminophen;PO acetaminophen
27 Ulcer Prevention Study in Post Gastric Bypass Patients Completed NCT00557349 Phase 4 Omeprazole;Famotidine
28 Opioid Effects on Swallowing and Esophageal Sphincter Pressure Completed NCT01191645 Phase 4 naloxone;remifentanil;Sodium Chloride;metoclopramide
29 To Evaluate the Effect of Chlorhexidine-benzidamine Administration Completed NCT03253497 Phase 4 Chlorobenzene Liquid
30 Opioid Effects on Swallowing Comparing Younger and Elderly Volunteers Completed NCT01924234 Phase 4 Morphine;Remifentanil
31 WallFlex Esophageal Fully Covered (FC) Benign Anastomotic Stricture Completed NCT01699542 Phase 4
32 Esophageal Fully Covered Metal Stents in Caustic Strictures Study Completed NCT01899300 Phase 4
33 Blind Intubation Through The Self-Pressurised Disposable Air-Q Laryngeal Intubation Mask: An International Multicentre Trial Completed NCT01906060 Phase 4
34 Comparing Hemodynamic Changes for Intubation With Shikani Intubating Stylet and Macintosh Laryngoscope Completed NCT01271543 Phase 4
35 Pharmacokinetics of Sublingual Versus Oral Tacrolimus in Patients Awaiting Kidney Transplantation Completed NCT00629122 Phase 4 Tacrolimus (Arm B);Clotrimazole Troche;Tacrolimus (Arm A);Nystatin Suspension
36 An Efficacy Study to Compare the Treatment Effects of Rabeprazole and Lansoprazole Depending on the Genotyping of CYP2C19 in Treating Reflux Esophagitis Completed NCT01008696 Phase 4 Rabeprazole;Lansoprazole
37 Nissen and Gastroplasty in Gastroesophageal Reflux Disease (GERD) Completed NCT00872755 Phase 4
38 A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive Esophagitis Completed NCT00641602 Phase 4 Esomeprazole;Lansoprazole
39 PROPRANOLOL PLUS LIGATION REDUCES RECURRENCE OF ESOPHAGEAL VARICES? Completed NCT01893541 Phase 4 PROPRANOLOL
40 Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia Completed NCT01851863 Phase 4 Omeprazole;Flupentixol-Melitracen(psychological and GI) + Omeprazole;Flupentixol-Melitracen(psychological) + Omeprazole;Flupentixol-Melitracen(without explanation) + Omeprazole
41 Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006) Completed NCT02256553 Phase 4 Rescue Medication
42 Safety and Efficacy of Lansoprazole in Patients With Reflux Disease Completed NCT01135368 Phase 4 Lansoprazole
43 Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR) Completed NCT00431041 Phase 4 solifenacin;oxybutynin immediate release
44 An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD) Completed NCT00242736 Phase 4 Esomeprazole
45 Efficacy and Safety of Meloxicam Suspension Versus Diclofenac Suspension or Nimesulide Suspension in Patients With a Diagnosis of Acute, Non-bacterial Pharyngitis, Pharyngotonsillitis or Laryngitis Completed NCT02229747 Phase 4 Meloxicam;Diclofenac;Nimesulide
46 Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults Completed NCT03154515 Phase 4 Ingavirin;Placebo
47 Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease Completed NCT02351960 Phase 4 Dexlansoprazole
48 Codeine on Pharyngeal and Esophageal Motility Completed NCT03784105 Phase 4 Codeine Phosphate;Siripus simplex
49 The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers Completed NCT02736734 Phase 4 CRH
50 A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study Completed NCT02049112 Phase 4

Search NIH Clinical Center for Dysphagia

Genetic Tests for Dysphagia

Genetic tests related to Dysphagia:

# Genetic test Affiliating Genes
1 Dysphagia 29

Anatomical Context for Dysphagia

MalaCards organs/tissues related to Dysphagia:

41
Brain, Testes, Tongue, Bone, Lung, Heart, Thyroid

Publications for Dysphagia

Articles related to Dysphagia:

(show top 50) (show all 2161)
# Title Authors Year
1
Dysphagia and pharmacotherapy in older adults. ( 30489400 )
2019
2
Systematic dysphagia screening and dietary modifications to reduce stroke-associated pneumonia rates in a stroke-unit. ( 29389984 )
2018
3
Dysphagia due to macroglossia in a patient with amyloidosis associated with multiple myeloma: A case report. ( 29889980 )
2018
4
Severe, reversible dysphagia and malnutrition in a patient with tumour-induced hypophosphataemia. ( 29950359 )
2018
5
Structural airway abnormalities contribute to dysphagia in children with esophageal atresia and tracheoesophageal fistula. ( 29429770 )
2018
6
Risk factors for dysphagia after a spinal cord injury: a systematic review and meta-analysis. ( 29955090 )
2018
7
Pediatric laryngeal cleft repair and dysphagia. ( 29287871 )
2018
8
Solitary anterior osteochondroma of cervical spine: An unusual cause of dysphagia and review of literature. ( 29928094 )
2018
9
Conus medullaris arteriovenous malformation presenting with acute dysphagia and intractable hiccups. ( 29305117 )
2018
10
An unusual cause of dysphagia in a child: Gastrointestinal manifestations of epidermolysis bullosa. ( 29923525 )
2018
11
Corrigendum: Image of the month: Dysphagia due to injury of the corticobulbar tract following traumatic brain injury. ( 29436459 )
2018
12
Pre-stroke undiagnosed dysphagia lusoria as a rare cause of aspiration pneumonia with respiratory failure in a stroke patient. ( 29552342 )
2018
13
The surgical management of dysphagia secondary to diffuse idiopathic skeletal hyperostosis. ( 29438856 )
2018
14
Dysphagia lusoria: a little-known cause of dysphagia. ( 29368939 )
2018
15
Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy. ( 29399642 )
2018
16
One-Year Risk of Pneumonia and Mortality in Patients with Poststroke Dysphagia: A Nationwide Population-Based Study. ( 29395642 )
2018
17
Clinical course and outcome in patients with severe dysphagia after lateral medullary syndrome. ( 29511384 )
2018
18
Aspiration Pneumonia as a Cause of Death in Critically Ill Patients with Dysphagia After Extubation. ( 29538126 )
2018
19
Dual Transcranial Direct Current Stimulation for Poststroke Dysphagia: A Randomized Controlled Trial. ( 29926772 )
2018
20
Neurogenic dysphagia with undigested macaroni and megaesophagus in familial dysautonomia. ( 29196937 )
2018
21
A rare cause of dysphagia: Pyriform sinus atypical lipomatous tumor. ( 29940678 )
2018
22
Tuberculous Paraspinal Abscess Invading Esophagus: A Rare Cause of Dysphagia. ( 29950266 )
2018
23
International consensus (ICON) on assessment of oropharyngeal dysphagia. ( 29396225 )
2018
24
Predictors of Patient-Reported Dysphagia Following IMRT Plus Chemotherapy in Oropharyngeal Cancer. ( 29948260 )
2018
25
Prevalence, Nature, and Management of Oral Stage Dysphagia in Adults With Temporomandibular Joint Disorders: Findings From an Irish Cohort. ( 29549021 )
2018
26
Effects of a swallowing exercise education program on dysphagia-specific health-related quality of life in oral cavity cancer patients post-treatment: a randomized controlled trial. ( 29546525 )
2018
27
Feeding experiences of nursing aides for residents with dysphagia. ( 29398011 )
2018
28
Creation and Initial Validation of the International Dysphagia Diet Standardisation Initiative Functional Diet Scale. ( 29428348 )
2018
29
Dysphagia Management in Iran: Knowledge, Attitude and Practice of Healthcare Providers. ( 29931606 )
2018
30
Introducing a Virtual Lesion Model of Dysphagia Resulting from Pharyngeal Sensory Impairment. ( 29402815 )
2018
31
Determining peak cough flow cut-off values to predict aspiration pneumonia among patients with dysphagia using the citric acid reflexive cough test. ( 29981313 )
2018
32
Dysphagia and associated clinical markers in neurologically intact children with respiratory disease. ( 29393599 )
2018
33
Which Provocation Test Will Be Added to Routine High-resolution Manometry Protocol in Unexplained Dysphagia? ( 29969853 )
2018
34
Dysphagia lusoria: uncommon cause of dysphagia in children. ( 29931991 )
2018
35
The impact of the difference in O-C2 angle in the development of dysphagia after occipitocervical fusion: a simulation study in normal volunteers combined with a case-control study. ( 29410299 )
2018
36
Analysis of dysphagia in advanced-stage head-and-neck cancer patients: impact on quality of life and development of a preventive swallowing treatment. ( 29978259 )
2018
37
Diagnostic accuracy of lip force and tongue strength for sarcopenic dysphagia in older inpatients: A cross-sectional observational study. ( 29398338 )
2018
38
Prevalence and association of oral candidiasis with dysphagia in individuals with acquired brain injury. ( 29182379 )
2018
39
Frequency and outcome of post-extubation dysphagia using nurse-performed swallowing screening protocol. ( 29968309 )
2018
40
Quantitative Risk Factor Analysis of Post-Operative Dysphagia After Anterior Cervical Discectomy and Fusion (ACDF) using the Eating Assessment Tool-10 (EAT-10). ( 29965886 )
2018
41
Short-Term Effects of Cold Liquids on the Pharyngeal Swallow in Preterm Infants with Dysphagia: A Pilot Study. ( 29435661 )
2018
42
Orofacial strength, dysarthria, and dysphagia in Congenital Myotonic Dystrophy. ( 29901230 )
2018
43
Cervical Hyperostosis Leading to Dyspnea, Aspiration and Dysphagia: Strategies to Improve Patient Management. ( 29740589 )
2018
44
The Dysphagia in Stroke Protocol Reduces Aspiration Pneumonia in Patients with Dysphagia Following Acute Stroke: a Clinical Audit. ( 29603057 )
2018
45
Oral phase dysphagia in facial onset sensory and motor neuronopathy. ( 29781209 )
2018
46
Interdisciplinary Telemedicine in the Management of Dysphagia in Head and Neck. ( 29404691 )
2018
47
Radiotherapy dose-volume parameters predict videofluoroscopy-detected dysphagia per DIGEST after IMRT for oropharyngeal cancer: Results of a prospective registry. ( 29961581 )
2018
48
Reversible dysphagia secondary to guttural pouch mycosis in a gelding treated medically with voriconazole and surgically with carotid occlusion and esophagostomy. ( 29386677 )
2018
49
Esophageal transit time in patients with chagasic megaesophagus: Lack of linear correlation between dysphagia and grade of dilatation. ( 29517674 )
2018
50
Dysphagia in myasthenia gravis: the tip of the Iceberg. ( 29417423 )
2018

Variations for Dysphagia

ClinVar genetic disease variations for Dysphagia:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 ZGRF1 NM_018392.4(ZGRF1): c.3596_3597delCT (p.Ser1199Cysfs) deletion Uncertain significance rs1057518892 GRCh38 Chromosome 4, 112587460: 112587461
2 ZGRF1 NM_018392.4(ZGRF1): c.3596_3597delCT (p.Ser1199Cysfs) deletion Uncertain significance rs1057518892 GRCh37 Chromosome 4, 113508616: 113508617
3 DNMT1 NM_001130823.2(DNMT1): c.2718C> G (p.Phe906Leu) single nucleotide variant Uncertain significance rs1057518774 GRCh38 Chromosome 19, 10148886: 10148886
4 DNMT1 NM_001130823.2(DNMT1): c.2718C> G (p.Phe906Leu) single nucleotide variant Uncertain significance rs1057518774 GRCh37 Chromosome 19, 10259562: 10259562

Expression for Dysphagia

Search GEO for disease gene expression data for Dysphagia.

Pathways for Dysphagia

Pathways related to Dysphagia according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
11.31 NDUFA10 NDUFA12 NDUFA9

GO Terms for Dysphagia

Cellular components related to Dysphagia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 mitochondrion GO:0005739 9.62 NDUFA10 NDUFA12 NDUFA9 SCO2
2 mitochondrial inner membrane GO:0005743 9.43 NDUFA10 NDUFA12 SCO2
3 mitochondrial matrix GO:0005759 9.33 NDUFA10 NDUFA9 SCO2
4 respiratory chain GO:0070469 9.13 NDUFA10 NDUFA12 NDUFA9
5 mitochondrial respiratory chain complex I GO:0005747 8.8 NDUFA10 NDUFA12 NDUFA9

Biological processes related to Dysphagia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 oxidation-reduction process GO:0055114 9.26 NDUFA10 NDUFA12 NDUFA9 SCO2
2 mitochondrial electron transport, NADH to ubiquinone GO:0006120 9.16 NDUFA10 NDUFA9
3 mitochondrial respiratory chain complex I assembly GO:0032981 8.8 NDUFA10 NDUFA12 NDUFA9

Molecular functions related to Dysphagia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 NADH dehydrogenase (ubiquinone) activity GO:0008137 8.8 NDUFA10 NDUFA12 NDUFA9

Sources for Dysphagia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....